Bruno Paiva

7 ta ish

Navarra University Clinic

1. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

   S. Vincent Rajkumar, Meletios Α. Dimopoulos, Antonio Palumbo +31

   Maqola20143 iqtibos

   ABIABI:AkademIndex/2026.other.466311

2. Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma

   Joaquín Martínez‐López, Juan José Lahuerta, François Pépin +21

   Maqola20142 iqtibos

   ABIABI:AkademIndex/2026.other.480111

3. Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma

   Juan‐José Garcés, María‐Teresa Cedena, Noemí Puig +25

   Maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.480203

4. More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia–Like Multiple Myeloma

   Tomáš Jelı́nek, Renata Bezděková, David Žihala +27

   Maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.480213

5. International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma

   Hervé Avet‐Loiseau, Faith E. Davies, Mehmet Samur +43

   Maqola20252 iqtibos

   ABIABI:AkademIndex/2026.other.480252

6. Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma

   Juan Flores‐Montero, Luzalba Sanoja-Flores, Bruno Paiva +30

   Maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.881528

7. Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report

   David Murray, Noemí Puig, Sigurður Y. Kristinsson +10

   Maqola20212 iqtibos

   ABIABI:AkademIndex/2026.other.890026